Cardiovascular Systems, Inc. Reports Fiscal 2021 Second-quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall St slips on rising bond yields; Walmart results weigh
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Deutsche Bank calls Treasury buyback doubling similar to ’operation twist’
Cardiovascular Systems (CSII) Tops Q2 EPS by 6c, Revenues Miss; Offers 3Q Revenue Guidance Below Consensus
February 3, 2021 4:43 PM ESTCardiovascular Systems (NASDAQ: CSII) reported Q2 EPS of $0.00, $0.06 better than the analyst estimate of ($0.06). Revenue for the quarter came in at $64.2 million versus the consensus estimate of $65.51 million.
Revenues of $64.2 million increased 6% sequentially compared to first quarterNet loss was $0.1 million, or $0.00 per basic and diluted shareManagement provides fiscal 2021 third quarter revenue guidance of $60 million to $65 millionReceives CE Mark for Diamondback 360® Coronary Orbital Atherectomy SystemSachin H.... More